The Complex PI Patient – Accreditation & Credit Designation Statement | Disclosures

The Complex PI Patient – Accreditation & Credit Designation Statement | Disclosures

Beyond Infection – Part 3 (Webinar Series) – The Complex Primary Immunodeficient Patient 

  • Jointly provided by Educational Review Systems and Ig National Society, Inc. (IgNS) 
  • This activity is supported by independent educational grants from Pfizer, Inc. and Takeda 

Target Audience
This activity is intended for pharmacists and nurses who care for patients with primary immunodeficiency. 

Learning Objectives
Upon completion of this activity, participants should be able to: 

  • Learn the range of disorders of host defense. 
  • Understand the non-infectious co-morbidities associated with PI. 
  • Discern pediatric and adult PI patient differences pertaining to treatment and clinical outcomes. 
  • Learn the complexity of PI patients’ comorbidities and risk factors. 

Planner and Faculty Disclosure of Financial Relationships
Educational Review Systems requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to Educational Review Systems policy. Educational Review Systems is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies: 

Faculty: Richard Wasserman, MD, PhD
Financial Relationships: Dr. Wasserman has no relevant financial relationship(s) to disclose with ineligible companies. 

The IgNS planners and others have no relevant financial relationship(s) to disclose with ineligible companies. 

Nursing Continuing Professional Development
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider #5-115. This program is approved for up to 1 hour of continuing nursing education. Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida, and the District of Columbia.

Pharmacy Continuing Education
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for up to 1 hour of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
 

(Universal Activity Number – 0761-9999-23-514-H01-P)
Type of Activity: Knowledge, Skills/Strategy 

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Instructions for Credit
Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from 9/2/2023 through 9/2/2025: 

  1. Review the objectives and disclosures 
  1. Study the educational content 
  1. Complete the activity evaluation at the end of the activity 

For Pharmacists: Upon completing the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted. 

Computer system hardware/software requirements: A computer with an internet connection is required. Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards-compliant browser. Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.